Drug news
Pfizer will not proceed with Lyrica for Restless Legs Syndrome
Pfizer will not proceed with regulatory approval for Lyrica (pregabalin), its GABA analogue, for Restless Legs Syndrome despite reporting positive Phase III results for the drug in this patient group.